Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Diagnosis Track

Non-invasive evaluation of CXCR4 expression of MALT lymphoma using 68Ga-Pentixafor PET/MRI- a prospective study

Asha Leisser, Marius Mayerhöfer, Markus Raderer, Wolfgang Wadsak, Markus Mitterhauser, Sarah Pfaff, Saskia Kropf, Hans Wester, Marcus Hacker, Markus Hartenbach and Alexander Haug
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 563;
Asha Leisser
5Medical University of Vienna Vienna Austria
6Medical University of Vienna Vienna Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marius Mayerhöfer
8Department of Biomedical Imaging and Image-guided Therapy Medical University of Vienna Vienna Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Raderer
9Hematology and Oncology Medical University of Vienna Vienna Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Wadsak
5Medical University of Vienna Vienna Austria
6Medical University of Vienna Vienna Austria
2CBmed Zentrum für Biomarkerforschung in der Medizin Graz Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Mitterhauser
1Vienna Austria
4Ludwig Bolzmann Gesellschaft Vienna Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Pfaff
10Meduni Wien Vienna Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saskia Kropf
11Scintomics GmbH Fürstenfeldbruck Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Wester
12Technische Universitaet Muenchen Garching Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Hacker
13Universitatsklinik Fur Radiologie Und Nuklearmediz Wien Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Hartenbach
7Biomedical Imaging and Image Guided Therapy Medical University of Vienna Vienna Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Haug
3Division of Nuclear Medicine Vienna Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 58 no. supplement 1 563

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2017.

Copyright & Usage 
© 2017

Author Information

  1. Asha Leisser5,6,
  2. Marius Mayerhöfer8,
  3. Markus Raderer9,
  4. Wolfgang Wadsak5,6,2,
  5. Markus Mitterhauser1,4,
  6. Sarah Pfaff10,
  7. Saskia Kropf11,
  8. Hans Wester12,
  9. Marcus Hacker13,
  10. Markus Hartenbach7 and
  11. Alexander Haug3
  1. 1Vienna Austria
  2. 2CBmed Zentrum für Biomarkerforschung in der Medizin Graz Austria
  3. 3Division of Nuclear Medicine Vienna Austria
  4. 4Ludwig Bolzmann Gesellschaft Vienna Austria
  5. 5Medical University of Vienna Vienna Austria
  6. 6Medical University of Vienna Vienna Austria
  7. 7Biomedical Imaging and Image Guided Therapy Medical University of Vienna Vienna Austria
  8. 8Department of Biomedical Imaging and Image-guided Therapy Medical University of Vienna Vienna Austria
  9. 9Hematology and Oncology Medical University of Vienna Vienna Austria
  10. 10Meduni Wien Vienna Austria
  11. 11Scintomics GmbH Fürstenfeldbruck Germany
  12. 12Technische Universitaet Muenchen Garching Germany
  13. 13Universitatsklinik Fur Radiologie Und Nuklearmediz Wien Austria

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2017 to August 2023

AbstractFullPdf
May 2017400
Jun 20174600
Jul 20172500
Aug 20173200
Sep 20171100
Oct 20172100
Nov 20172500
Dec 2017600
Jan 20182600
Feb 20181400
Mar 20181100
Apr 20181000
May 20181100
Jun 2018300
Jul 2018900
Aug 2018200
Sep 20182100
Oct 20181200
Nov 20181600
Dec 2018500
Jan 2019800
Feb 20191200
Mar 20191500
Apr 2019700
May 2019200
Jun 2019100
Jul 2019100
Aug 2019300
Sep 2019100
Oct 2019300
Nov 2019400
Jan 2020100
Feb 20201000
Mar 20201600
Apr 20201200
May 2020300
Jul 2020800
Aug 20201200
Sep 20202100
Oct 2020900
Nov 20201500
Dec 2020900
Jan 2021300
Feb 20211200
Mar 2021500
Apr 20211600
May 2021900
Jun 2021600
Jul 20211800
Aug 20213000
Sep 20211300
Oct 20211400
Nov 20219500
Dec 20214300
Jan 20227200
Feb 20222700
Mar 20221300
Apr 2022800
May 20222700
Jun 2022700
Jul 2022300
Aug 2022700
Sep 2022600
Oct 2022300
Nov 2022400
Dec 2022200
Jan 2023300
Feb 2023400
Mar 2023200
Apr 2023400
May 2023900
Jun 2023700
Jul 2023500
Aug 2023600
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Non-invasive evaluation of CXCR4 expression of MALT lymphoma using 68Ga-Pentixafor PET/MRI- a prospective study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Non-invasive evaluation of CXCR4 expression of MALT lymphoma using 68Ga-Pentixafor PET/MRI- a prospective study
Asha Leisser, Marius Mayerhöfer, Markus Raderer, Wolfgang Wadsak, Markus Mitterhauser, Sarah Pfaff, Saskia Kropf, Hans Wester, Marcus Hacker, Markus Hartenbach, Alexander Haug
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 563;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Non-invasive evaluation of CXCR4 expression of MALT lymphoma using 68Ga-Pentixafor PET/MRI- a prospective study
Asha Leisser, Marius Mayerhöfer, Markus Raderer, Wolfgang Wadsak, Markus Mitterhauser, Sarah Pfaff, Saskia Kropf, Hans Wester, Marcus Hacker, Markus Hartenbach, Alexander Haug
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 563;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Diagnosis Track

  • Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (68Ga-RM2) PET/CT
  • Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
  • Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of SUVmax
Show more Oncology, Clinical Diagnosis Track

Lymphoma - Adult

  • The role of FDG PET/CT in staging and restaging primary bone lymphoma
  • FDG PET/CT for characterization of indeterminate lymphadenopathy: can PET feasibly function as a "metabolic biopsy"
  • 68Ga-pentixafor PET/CT in diagnosis of lymphoma in gastrointestinal tract
Show more Lymphoma - Adult

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire